Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lactiplantibacillus plantarum FB00015
- Development stage
- Unknown
- Lead developer
- FitBiomics
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Lactiplantibacillus plantarum FB00015 is a specific probiotic strain developed by FitBiomics. It is one of three proprietary strains included in the probiotic product "Nella," which is designed to improve the quality of sleep by leveraging gut immune and gut-brain benefits. As a strain of Lactiplantibacillus plantarum, it is expected to exert its beneficial effects through mechanisms common to the species, such as inhibiting pathogenic bacteria by producing antimicrobial substances, modulating the immune system by interacting with gut-associated lymphoid tissue, enhancing gut barrier function, and fermenting undigested carbohydrates to produce short-chain fatty acids (SCFAs). This particular strain is derived from the gut microbiomes of elite athletes.
- Brand names
- Nella
- Other names
- lactobacillus plantarum FB0015Lactobacillus plantarumLactiplantibacillus plantarum
Beyond the preview
Go deeper on Lactiplantibacillus plantarum FB00015.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lactiplantibacillus plantarum FB00015.